Business Description
Iambic Therapeutics is a San Diego-based biotechnology company founded in 2019 that uses artificial intelligence to discover and develop new cancer drugs. The company's proprietary AI platform helps identify and refine small molecule drug candidates, with several programs currently in development targeting proteins involved in tumor growth. Formerly known as Entos Inc., the company rebranded in 2023 and operates across both U.S. and international markets.
